Why Smartwire?

Outstanding Reliability

Through patented technology (Patent No. 10-2327714, US/Europe patent pending), Smartwire achieves sufficient tensile strength, cutting ability, ultrasound visibility, and maneuverability, making it an optimized medical device for "ultrasound-guided, minimally invasive ligament release surgery." ("What is Smartwire")

In the surgical technique, the area where the loop is formed with the Smartwire is completely resected, reducing the possibility of incomplete release of the transverse carpal ligament, which is a potential cause of recurrence after surgery.

ultrasound

The Smartwire is the only product officially certified/approved for use in domestic surgeries of this type through the Ministry of Health and Welfare, and it has received the designation as an innovative medical device by the Ministry of Food and Drug Safety (MFDS), along with NET (New Excellent Technology) certification.

Outstanding versatility

In patients with Grade 6 (extremely severe) CTS, where APB atrophy is significant, Smartwire has demonstrated superior efficacy compared to traditional open surgery, and it can be safely performed even in patients with anatomical variations.

Smartwire can be safely performed even in patients with conditions such as median nerve swelling or bifid median nerve, where there is no safety zone (the space between the median nerve and ulnar artery).

Long-Term Outcomes of Ultrasound-Guided Thread Carpal Tunnel Release and Its Clinical Effectiveness in Severe Carpal Tunnel Syndrome: A Retrospective Cohort Study. Journal of Clinical Medicine, 2024 (the related papers)

Educational Support

Cadaver Workshop Application -> Workshop Completion -> Supervision Program (if necessary) -> Procedure Execution -> Collaboration Hospital Registration

Workshop Inquiry and Supervision Program Application : threadreleasekorea@gmail.com

Purchase Inquiry

We kindly ask for your understanding that the sale is only available to those who have completed the Cadaver Workshop organized by the Minimally Invasive Pain Study Group for safe procedures.

Privacy Policy | Prohibition of Unauthorized Email Collection

Address: 34 Mugunghwa-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, South Korea
CEO: In Jong Kim    Phone: 070-8064-7519    eMail: threadreleasekorea@gmail.com

Copyrightⓒ 2025 All rights reserved.